THE APPLICATION OF PHARMACOMETABOLOMICS TO PREDICT THE PHARMACOKINETICS OF TACROLIMUS IN HEALTHY KOREAN SUBJECTS.

被引：0
|
作者：
Lim, M. [1 ]
Phapale, P. [1 ]
Kim, S. [1 ]
Lee, H. [1 ]
Lee, W. [1 ]
Yoon, Y. [1 ]
机构：
[1] Kyungpook Natl Univ Hosp, Clin Trial Ctr, Taegu, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF DRONEDARONE ON PHARMACOKINETICS AND PHARMACODYNAMICS OF LOSARTAN IN HEALTHY SUBJECTS.
    Bonnet, Denis
    Galleyrand, Jacques
    Brunet, Aurelie
    Sultan, Eric
    Gaud, Christine
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1080 - 1080
  • [22] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF INHALED REMDESIVIR IN HEALTHY SUBJECTS.
    Humeniuk, R.
    Juneja, K.
    Chen, S.
    Ellis, S.
    Xiao, D.
    Share, A.
    Johnston, M.
    Davies, S.
    Blair, C.
    Osinusi, A.
    Girish, S.
    Palaparthy, R.
    Dresser, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S26 - S26
  • [23] PHARMACOKINETICS AND PHARMACODYNAMICS CHARACTERISTICS OF ZOLPIDEM IN MALE AND FEMALE KOREAN SUBJECTS.
    Yoon, S.
    Kim, K.
    Jeong, S.
    Jung, E.
    Oh, W. -Y.
    Chung, J.
    Chung, J. -Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S77 - S77
  • [24] PHARMACOKINETICS OF UPADACITINIB IN HEALTHY JAPANESE AND CHINESE SUBJECTS AND COMPARABILITY TO WESTERN SUBJECTS.
    Mohamed, M-E. F.
    Camp, H. S.
    Jungerwirth, S.
    Othman, A. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S80 - S80
  • [25] Effects of CYP2C9 polymorphism on the pharmacokinetics and pharmacodynamics of meloxicam in healthy korean subjects.
    Bae, J.
    Kim, M.
    Song, Y.
    Sa, J.
    Choi, C.
    Jang, C.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S31 - S31
  • [26] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VALBENAZINE AFTER SINGLE AND MULTIPLE ORAL ADMINISTRATION IN HEALTHY KOREAN MALE SUBJECTS.
    Chung, W.
    Huh, K.
    Ka, J.
    Bae, S.
    Oh, J.
    Yoon, S.
    Jang, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S15 - S15
  • [27] Evaluation of the pharmacokinetics and safety/tolerability of avanafil, a novel phosphodiesterase type 5 inhibitor in healthy Korean subjects.
    Jung, J. A.
    Choe, S. M.
    Cho, S. H.
    Ghim, J. L.
    Kim, U. J.
    Lim, H. S.
    Bae, K. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S27 - S27
  • [28] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF TEDIZOLID PHOSPHATE AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY KOREAN SUBJECTS.
    Kim, Y.
    Kim, A.
    Rhee, S.
    Yoon, S.
    Lee, H.
    Jang, I.
    Yu, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S21 - S21
  • [29] Effects of genetic polymorphism of CYP2C9 on the pharmacokinetics of lornoxicam in healthy Korean subjects.
    Bac, J.
    Kim, N.
    Lee, H.
    Lee, J.
    Jung, D.
    Kim, M.
    Jang, C.
    Lee, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S33 - S34
  • [30] Population pharmacokinetics of aripiprazole in healthy Korean subjects
    Jeon, Ji-Young
    Chae, Soo-Wan
    Kim, Min-Gul
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 293 - 304
12345